⌘K

Login Start Free

Home/Filings/4/0001209191-15-051551

4//SEC Filing

SYNAGEVA BIOPHARMA CORP 4

Accession 0001209191-15-051551

CIK 0000911326operating

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 6:18 PM ET

Size

4.8 KB

Accession

0001209191-15-051551

Insider Transaction Report

Form 4

Period: 2015-06-05

SYNAGEVA BIOPHARMA CORPGEVA

Vice President, Finance

Transactions

Award
Common Stock
2015-06-05+24,000→ 24,390 total

Footnotes (1)

[F1]Award of Restricted Stock Units under the 2014 Equity Incentive Plan. Vests (x) 25% on June 5, 2016 and (y) 12.5% per six months thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SYNAGEVA BIOPHARMA CORP

CIK 0000911326

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000911326

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 6:18 PM ET
Size: 4.8 KB

View on SEC.gov